ion-channel regulation; cardiac arrhythmias; calcium channels; potassium channels; sympathetic nervous system VENTRICULAR TACHYARRHYTHMIAS are a common cause of mortality among patients with congestive heart failure (4, 36, 38) . Repolarization abnormalities are prominent in patients and experimental animals with heart failure and are believed to be important in ventricular arrhythmogenesis (31) . Several abnormalities in ionic currents have been noted in cardiomyocytes of subjects with severe cardiac dysfunction, and these abnormalities are thought to contribute to arrhythmogenesis and the risk of sudden death in heart failure (26, 38) .
The adrenergic nervous system clearly contributes to determining the prognosis in patients with heart failure. Plasma norepinephrine concentration is a highly significant determinant of mortality (5) and ␤-adrenoceptor antagonists reduce mortality, including sudden arrhythmic death, in patients with heart failure (30) . Ion channels are potential signal transduction mediators between physiological stimuli and the hypertrophic response, and ␤-receptor activation contributes to the development of myocardial hypertrophy and failure (25) . The mortality-promoting role of ␤-adrenergic activation in patients with heart failure has been related to its contribution to hypertrophy, as well as to immediate electrophysiological changes via cAMP-dependent regulation of cardiac ion-channel function. The possibility that sustained exposure to adrenergic agonists may regulate ion channel function has received less attention. This study was designed to evaluate the effects of 48 h of exposure to isoproterenol on K ϩ and Ca 2ϩ currents of adult guinea pig ventricular myocytes, along with adrenergic receptor subtype(s) and signal transduction system(s) involved.
MATERIALS AND METHODS
Myocyte isolation. Guinea pigs weighing 350-450 g were euthanized by cervical dislocation. The hearts were quickly excised and mounted on a Langendorff apparatus. Retrograde aortic perfusion was performed with oxygenated (100% O 2, pH adjusted to 7.35 with NaOH) Tyrode solution (for composition, see Solutions) at 37°C. When clear of blood, the perfusate was changed to a nominally Ca 2ϩ -free Tyrode solution until contraction ceased (generally ϳ2 min). Perfusion was continued with the same solution containing 140 U/ml collagenase (type 2, Worthington Biochemical) and 1% bovine serum albumin (Sigma) until the ventricular tissue was softened (ϳ20 min). Small pieces of right ventricular free wall tissue were removed with a forceps and mechanically dissociated by trituration. The isolated cells were initially kept in a storage solution containing (in mM) 20 KCl, 10 KH 2PO4, 25 glucose, 40 mannitol, 70 L-glutamic acid, 10 ␤-hydroxybutyric acid, 20 taurine, and 10 EGTA, along with 1% albumin (pH adjusted to 7.35 with KOH). Cells were concentrated by centrifugation at 250 rpm, and the pellet was removed for culture. All procedures were performed with aseptic technique.
Cell culture and treatment. Nunclon Delta petri dishes (35 mm, Nunc) were used. Medium-199 (GIBCO-BRL, Life Technologies, containing Earle  ' s salts, L-glutamine, and 2,200 mg/l NaHCO3) with 10% fetal bovine serum was supplemented with Na-penicillin G (50 U/ml) and streptomycin sulfate (1 g/ml) for the cell culture. Cells were plated at low density (ϳ10 4 cells/cm 2 ) onto square glass coverslips coated with laminin (20 g/ml) and maintained in the medium at 37°C in a humidified, 5% CO 2-enriched atmosphere. After 4 h, any dead or unattached myocytes were washed off to leave a homogeneous layer of rod-shaped cells attached to the coverslips. Fresh medium was then added containing 10 nM isoproterenol (Iso medium), 10 nM isoproterenol plus 1 M propranolol (Iso ϩ Prop medium), or vehicle alone (control medium). The vehicle contained ascorbic acid (100 M in distilled water) to prevent isoproterenol oxidation. In some experiments, subtype-selective ␤-adrenoceptor antagonists (3, 35, 41) were added to isoproterenol-containing culture medium: 300 nM CGP-20712A methanesulfonate to inhibit ␤ 1 adrenoceptors or 50 nM ICI-118,551 hydrochloride (ICI) to inhibit ␤ 2 adrenoceptors.
Electrophysiological studies on cultured cells were conducted after 2 days in culture. Isoproterenol and (when applicable) propranolol that had been included in the culture medium were washed out of the bath for at least 20 min before we made any measurements in any experiments. For each set of experiments, parallel studies were performed with cells cultured in the presence of each experimental group and control medium (i.e., data were not transferred for comparisons across studies), to exclude as much as possible the role of variability in current densities across hearts or isolates. The number of cells indicated for each set of experiments is therefore specific for those experiments; control data were obtained in separate cells for each study.
Solutions. Tyrode solution contained (in mM) 136 NaCl, 2 CaCl2, 5.4 KCl, 0.8 MgCl2, 0.33 NaH2PO4, and 10 dextrose, HEPES; pH 7.4 (NaOH). This solution was used for cell isolation and as the extracellular solution for action potential recording and was modified as indicated below when specific currents were studied. The pipette solution for K ϩ current studies contained (in mM) 0.1 GTP, 110 K-aspartate, 20 KCl, 1.0 MgCl2, 5 Mg2-ATP, 10 HEPES, 5 Na2-phosphocreatine, and 10 EGTA; pH 7.2 (KOH). For action potential recording, the pipette solution was modified by reducing EGTA concentration to 50 M (to allow for physiological intracellular Ca 2ϩ transients) and setting the pH at 7.2. When K ϩ currents were recorded, Cd 2ϩ (200 M) was added to the Tyrode solution to inhibit L-type Ca 2ϩ current (ICa L). In studies of delayed rectifier K ϩ current (IK) dofetilide (1 M) was used to separate the drug-sensitive rapid component (IKr) from the drugresistant slower component (IKs). The extracellular solution for Ca 2ϩ current (ICa) studies contained (in mM) 136 TEA-Cl, 5.4 CsCl, 1.0 MgCl2, 2.0 CaCl2, 0.33 NaH2PO4, 10 dextrose, and 10 HEPES; pH 7.4 (CsOH). The pipette solution for ICa recording contained (in mM) 135 CsF, 5.0 NaCl, 5.0 HEPES, 10 EGTA, and 5 Mg2-ATP (pH adjusted to 7.2 with CsOH). CsF was used to evaluate ICa with full cAMP activation. Additional experiments were conducted with CsCl instead of CsF in the pipette to evaluate effects on unstimulated ICa. Data acquisition. After 2 days in culture, medium was washed out with Tyrode solution, the coverslip was placed in an inverted microscope, and the cells were perfused with Tyrode solution containing 1 M propranolol to block any potential effects of residual isoproterenol bound to the membrane (except in experiments assessing the response to acute isoproterenol administration, for which propranolol was omitted). A limited number of selected experiments were also performed in freshly isolated myocytes, as specified in RE-SULTS. Experiments were performed at 36 Ϯ 1°C with the use of a temperature control system (model TC-202, Medical Systems). The whole cell patch-clamp technique was used to record currents in voltage-clamp mode and action potentials in current-clamp mode. Borosilicate glass electrodes (1.0 mm outer diameter) were filled with a pipette solution and connected to a patch-clamp amplifier (Axopatch 200A, Axon Instruments). Electrodes with tip resistances of 1-3 M⍀ were used to record whole cell currents, and tip resistances were 3-5 M⍀ when action potentials were recorded. Action potentials were elicited by 2 ms, twice-threshold pulses, and were recorded at 1 Hz. Action potential duration (APD) was measured to 20 (APD 20), 50 (APD50), and 90% (APD90) of full repolarization. Only cells in which action potentials were stable for at least 10 min were used for analysis. Action potential measurements were begun 5 min after cell rupture. Voltage command pulses were generated by a 12-bit digitalto-analog converter controlled by pCLAMP6 software (Axon). Recordings were low-pass filtered at half the sampling frequency. Data were sampled at rates varying from 2 to 10 kHz (with sampling at 10 kHz used for the action potential and the rapidly activating currents such as I Ca and sampling at 2 kHz used for slower currents like IK) and then stored on the hard disk of an IBM-compatible computer.
Liquid junction potentials (2-8 mV) were zeroed before formation of the membrane-pipette seal in Tyrode solution. Junction potentials between the bath and pipette solution averaged 10 mV and were corrected for action potentials only. After gigaseal formation (seal resistance Ͼ10 G⍀), gentle suction was applied to rupture the membrane for whole cell recording. Cell capacitance was measured as the integral of the current carried during the capacitive surge upon 5-mV hyperpolarizations from Ϫ60 mV divided by the voltage drop. Capacitance was larger in isoproterenol-treated myocytes (87.0 Ϯ 2.6 pF, n ϭ 111 vs. 76.6 Ϯ 2.4 pF for vehicle alone, n ϭ 108; P ϭ 0.004). To control for differences in cell size, all mean current data are expressed as current densities (i.e., normalized to capacitance). The deactivating current after repolarization following an activating pulse (I K tail) and ICa current amplitudes were measured from the peak current amplitude to the steady-state values at the end of the voltage step. I K step was measured from the initial current value at the onset of each depolarizing step to the value at the end of the pulse. I K1 was measured in two ways: both from the holding current to the peak value during a test pulse (peak I K1) and to the steady-state level at the end of the pulse (steady-state IK1). Series resistance averaged 7.7 Ϯ 0.2 and 1.9 Ϯ 0.1 M⍀ before and after compensation, respectively. Cells with significant leak currents were rejected, and leakage compensation was not applied.
Statistical analysis. Group data are expressed as means Ϯ SE. Nonlinear curve fitting was performed with the Clampfit routine in pCLAMP (Chebyshev algorithm). Statistical comparisons among groups were performed with analysis of variance (ANOVA). A t-test with Bonferroni's correction was used to evaluate differences between individual mean values. A two-tailed P Ͻ 0.05 was taken to indicate statistical significance.
RESULTS

Changes in cellular phenotype in culture.
To evaluate the effects of 48 h of isoproterenol exposure on ion channel properties, the cell had to be maintained in primary culture for this period. (Fig. 1) . Cultured cells maintained relatively normal action potentials, but phase 3 repolarization became somewhat slower and the resting potential was slightly depolarized. I K1 density was reduced by cell culture ( Fig. 2A) , consistent with the reduced resting potential and phase 3 slope. I Ca density was also decreased (Fig. 2C) . On the other hand, I K density was unaltered (Fig. 2C) .
Effects of isoproterenol on action potentials and K ϩ currents of cultured cells. Typical action potentials from cells cultured in Iso medium had a shortened plateau and triangular shape (Fig. 1C) , whereas cells in Iso ϩ Prop medium had action potentials (Fig. 1D ) similar to cells (Fig. 1B) cultured in control medium. Mean action potential characteristics are provided in Table 1 and indicate that isoproterenol significantly decreased resting potential and early phase APD but that with phase 3 repolarization slowing, terminal repolarization time remained unaffected. Figure 3 illustrates the effect of 2 days of culture in Iso medium on I K1 . Figure 3 , A and B, shows representative I K1 recordings from myocytes cultured in control and Iso media, respectively. Both peak (Fig. 3C ) and end-pulse (Fig. 3D ) I K1 densities were decreased in myocytes cultured in Iso medium compared with myocytes cultured in control or Iso ϩ Prop medium, which were not different from each other. Normalized current density-voltage relations were superimposable for all groups (Fig. 3, E and F) , indicating that 48-h isoproterenol exposure did not affect the voltage dependency of I K1 . Initial measurements were performed 10 min after membrane rupture, and the protocol was repeated three times at 10-min intervals to exclude cells with Ͼ10% I K rundown over 20 min. Mean step currents (Fig. 4C) indicate that Iso medium significantly decreased I Ks density compared with control and Iso ϩ Prop medium. The inset in Fig. 4C shows current densities normalized to maximum values in each cell and indicates that isoproterenol did not alter the form of the current-voltage relation. Results for tail current density (Fig. 4D) 
Acute exposure to isoproterenol is well known to increase I K . We therefore considered the possibility that maintained isoproterenol exposure downregulated ␤-adrenergic responsiveness and examined the Values are means Ϯ SE; n, number of cells. The results shown are for fresh cells and cells cultured for 48 h in vehicle alone (CTL), 10 nM isoproterenol (Iso), or 10 nM Iso plus 1 M propranolol (Iso ϩ Prop); AP, action potential; APD20, APD50, APD90 AP duration to 20, 50, and 90% repolarization, respectively; Vm, resting membrane potential. * P Ͻ 0.05, † P Ͻ 0.01, ‡ P Ͻ 0.05, § P Ͻ 0.01 vs. CTL. Fig. 3 . Effects of Iso medium on IK1. Original recordings are shown for a cell cultured in control medium (A) and Iso medium (B). C: peak IK1 density-voltage relations (means Ϯ SE). D: steady-state IK1 density-voltage relations. Peak currents (E) and steady-state currents (F) are normalized to maximum value in each cell (means Ϯ SE). Voltage protocol (A, inset, 300-ms pulses) was applied at 0.2 Hz. CTL, n ϭ 59; Iso, n ϭ 49; Iso ϩ P, n ϭ 15. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. CTL.
acute response of I K in cultured cells to isoproterenol. The left panels in Fig. 5 show I K recorded in the absence of isoproterenol in cells that had been cultured in control medium (top), Iso medium (middle), and Iso ϩ Prop medium (bottom). The right panels show currents after acute exposure to 1 M isoproterenol in the same cells shown at the left. The mean data in the right panels are percent increases at ϩ60 mV in 13, 16, and 10 cells from each group. Isoproterenol increased I K to a comparable extent in all three groups (P ϭ not significant for intergroup differences), arguing against changes in ␤-adrenergic regulation of I K in cells cultured in Iso medium. We also evaluated the effect of acute isoproterenol exposure (100 nM) on I K1 in fresh cells. Isoproterenol decreased I K1 density at Ϫ100 mV in six fresh cells from Ϫ39.5 Ϯ 1.7 pA/pF to Ϫ33.1 Ϯ 1.8 pA/pF (P Ͻ 0.02), a response qualitatively similar to that produced by 48-h isoprotererol exposure.
To evaluate the receptor system involved in I K downregulation, cells were cultured (48 h) in Iso medium with or without each of two selective ␤-adrenergic receptor blockers: 300 nM CGP-20712A (CGP) and 50 nM ICI (␤ 1 -and ␤ 2 -selective, respectively) (3, 35, 41) . Figure 6 shows original recordings and mean data for each group of cells. CGP, the ␤ 1 -receptor antagonist, fully prevented isoproterenol-induced downregulation of I K , whereas ICI, the ␤ 2 -antagonist, had no effect: I K was just as small in the isoproterenol-ICI-cultured cells as in the cells cultured in Iso medium alone. These results indicate that the isoproterenol response is mediated solely by ␤ 1 -adrenoreceptors.
␤-Adrenergic agonists are capable of modifying ionic currents via either indirect mechanisms involving cAMP or by direct membrane-delimited signaling (8).
To evaluate the potential role of cAMP in isoproterenol-induced current downregulation, additional parallel studies were performed with cells cultured in control medium, Iso medium, and membrane-permeable 8-bromo-cAMP (8-Br-cAMP, 50 M). The density of I K (Fig. 7A ) and I K1 (Fig. 7B) was reduced significantly by 8-Br-cAMP, with changes quantitatively very similar to those caused by isoproterenol. Thus the downregulation of K ϩ channels by sustained ␤-adrenergic stimulation is likely due to consequent increases in intracellular cAMP concentrations, rather than a direct, membrane-delimited pathway.
Effects of isoproterenol on calcium current. rundown was excluded by using a standard depolarizing pulse to ϩ10 mV after each protocol and measuring peak I Ca . If I Ca decreased by over 5%, the experiment was terminated and the data were discarded. Compared with control medium, I Ca density was significantly reduced in Iso medium at voltages positive to Ϫ20 mV (Fig. 8D ). Isoproterenol added a "shoulder" to the normalized current-voltage relation negative to Ϫ10 mV (Fig. 8E) , consistent with increased T-type Ca 2ϩ current (I Ca T ), which could explain the lack of isoproterenol-induced I Ca decrease at test potentials negative to Ϫ10 mV (Fig. 8D) . Isoproterenol did not alter the inactivation time course of I Ca (Fig. 8F) . Additional experiments were performed with CsClcontaining pipettes to measure unstimulated I Ca . Isomedium cells had a peak I Ca at ϩ10 mV averaging 6.7 Ϯ 0.9 pA/pF (n ϭ 11) compared with 13.5 Ϯ 1.1 pA/pF (n ϭ 14, P Ͻ 0.001) for control medium. As shown in Fig. 7C , isoproterenol downregulation of I Ca was mimicked by 8-Br-cAMP, indicating that it is mediated by increased intracellular cAMP.
To evaluate possible effects of isoproterenol on I Ca T , a previously described approach (11, 39) was used to quantify I Ca T . I Ca was recorded at holding potentials of Ϫ90 and Ϫ50 mV in each cell, with I Ca T given by digital subtraction of recordings at a holding potential of Ϫ50 mV from those at a holding potential of Ϫ90 mV. Figure 9A shows resulting recordings of I Ca T in myocytes cultured in control medium (top) and in Iso medium (bottom). The form of the I Ca T density voltage relation (Fig. 9B) was similar for both sets of cells, but Iso medium significantly increased I Ca T over the entire voltage range.
DISCUSSION
We have shown that 48 h of isoproterenol exposure downregulates I K1 , I Ks , and I Ca L in guinea pig ventricular myocytes and increases the density of I Ca T . The actions of isoproterenol on I K were mediated by ␤ 1 -adrenergic receptors and were mimicked by a membrane-permeable form of cAMP, indicating the involvement of cAMP as a second messenger.
Relationship to previously observed effects of ␤-adrenergic stimulation on cardiac ion channels. Sympathetic stimulation of the heart is well known to be associated with the initiation of cardiac arrhythmias with ␤-adrenoceptor activation known to play a particularly important role (42) . Acute ␤-adrenergic stimulation enhances a variety of cardiac ionic currents, including I Ks (34) , I Ca L (32) , and cAMP-dependent Cl Ϫ current (10), and reduces I K1 (14). Much less is known about the effects on cardiac ion channels of longer term exposure to ␤-adrenergic agonists. Sympathetic innervation increases I Ca L density of cultured neonatal rat ventricular myocytes (28) , an effect likely mediated by Fig. 5 . Effects of acute Iso (1 M) on IK in cells from groups (GP) cultured in control (top), Iso (middle), and Iso ϩ Prop (bottom) media. Typical recordings are shown before (A) and after (B) acute exposure to Iso in a control cell, before (C) and after (D) acute Iso in an Iso medium-cultured cell, and before (E) and after (F) acute Iso in an Iso ϩ Prop medium-cultured cell. The voltage protocol applied was as in Fig. 3 . Percent Iso-induced IK increases at ϩ60 mV are indicated in right. Control, n ϭ 13; Iso, n ϭ 16; Iso ϩ Prop, n ϭ 10.
␤-adrenoceptors via increased intracellular cAMP content (18). Sympathetic innervation of newborn rat hearts increases the transient outward current (I to ) and I K1 density (17). The only study we could identify of ␤-adrenergic effects on adult cardomyocytes showed that norepinephrine and isoproterenol increase I to density in cultured adult canine ventricular myocytes without normalizing slowed inactivation kinetics (29) . Meszaros et al. evaluated the effects of sustained isoproterenol administration in vivo to rats, observing decreases in I to with no changes in voltage dependence of kinetics (22) and increased I Ca but no changes in current density or kinetics (23) . These results show that in vivo isoproterenol administration produces ionic remodeling and are consistent with results in other models of cardiac hypertrophy and failure (38) ; however, because of changes in cardiac work, hemodynamics, and oxygen consumption in the in vivo system, they do not permit differentiation between effects secondary to these factors and direct actions of ␤-adrenergic stimulation.
Isoproterenol increases I K acutely (1, 8) and was found similarly to increase I K during short-term administration to our cells. Decreased I K in the face of 48-h isoproterenol exposure could be related to adaptive cellular responses to chronic I K stimulation. However, we did not find evidence of tolerance to isoproterenol effects on I K in cells exposed to the drug for 48 h.
Furthermore, I K1 downregulation was seen after 48 h of isoproterenol exposure, an effect qualitatively similar to that on I K , despite the fact that upon acute exposure isoproterenol decreased I K1 , an acute response opposite to that of I K .
Comparison between isoproterenol-induced changes in the present study and previous observations of ionic remodeling in disease states. A variety of changes in cardiac ionic currents have been observed in patients or experimental models with cardiac disease, particularly congestive heart failure (26, 38) . Decreased I K1 has been observed in both patients (2) and experimental animals (12) with severe cardiac dysfunction. Changes in I Ca L are more variable, with some studies reporting no change and others reporting a decrease. Of 19 studies of I Ca L and/or dihydropyridine receptors in severe hypertrophy and failure presented by a recent detailed review (38) , 6 report no change and 13 describe a decrease. Recent studies have also pointed to a decrease in I Ks in cardiac hypertrophy and failure (13, 15, 16, 40) . Cardiac hypertrophy has been shown to elicit the appearance of I Ca T in feline ventricular myocytes (27) . Many of the effects of 48-h isoproterenol exposure in the present study, including decreased I K1 , I Ks , and I Ca L , as well as increased I Ca T , resemble changes associated with congestive heart failure. Although many other signaling systems likely play a role in ventricular remodeling, including that of ion chan- nels in heart failure, the possibility should be considered that at least some of the ionic current abnormalities could be due to downregulation by the associated chronically elevated plasma catecholamine concentrations (5).
Novel aspects and potential significance. We found that 48-h isoproterenol exposure had significant effects on a variety of ionic currents in guinea pig ventricular myocytes. These effects were opposite to the actions of acute isoproterenol in the case of I K and I Ca and similar in the case of I K1 . The effects of 48-h isoproterenol exposure were not contaminated by agonist occupancy of ␤-adrenergic receptors, because the medium was thoroughly washed out and propranolol (1 M) added to the extracellular solution when measurements were made. In considering the role of ␤-adrenergic stimulation and the well-recognized protective effect of ␤-adrenoceptor blockers in patients with heart disease, acute effects on ionic currents and electrophysiology are generally invoked. However, our study indicates an additional possibility that needs to be considered: the potential regulatory effect of the chronic level of ␤-adrenoceptor occupancy on the density of cardiac ion currents.
Plasma concentrations of norepinephrine average about 1 nM in normal individuals (20) and increase to a mean range of 3.4-5.5 nM in patients with heart failure (7, 9, 20). Interstitial (extracellular) space norepinephrine concentration is increased from ϳ1 nM in normal dogs to an average of 6.6 nM in dogs with pacing-induced heart failure (6). Thus extracellular norepinephrine concentration in congestive heart fail- ure is of a similar order to the extracellular concentration of isoproterenol (10 nM) in our culture medium. Ionic current alterations caused by chronic ␤-adrenergic stimulation may therefore play a significant role in the electrophysiological abnormalities caused by heart failure. Consistent with this notion, dogs with congestive heart failure and spontaneous ventricular tachyarrhythmias have higher plasma norepinephrine concentrations (ϳ6.6 nM) compared with dogs with similar cardiac dysfunction and no ventricular tachyarrhythmias (3.6 nM) (33) . Our findings may also be relevant to the effects of drug therapy on mortality in patients with heart failure, providing potential mechanisms involved in the ability of ␤-adrenoceptor antagonists to prevent sudden death (21) and in the mortality-promoting properties of agents that stimulate ␤-receptors or increase cardiac cAMP concentrations (19).
Potential limitations. The properties of cultured heart cells are never identical to those of acutely isolated myocytes, a limitation common to all studies using cultured cardiac cell models (24) . On the other hand, there is no other approach that would permit the study of the effects of sustained exposure to ␤-adrenergic stimulation without the important changes in hemodynamics, concentrations of other neurohormones, heart rate, etc., inevitable for in vivo models. Effects unrelated to ␤-adrenoceptor activation and due to nonspecific drug actions or the effect of the diluents need to be considered; however, the use of a control group of cells exposed to diluent alone and cells exposed to isoproterenol and a ␤-blocker for each set of experiments should have excluded such possibilities.
In conclusion, we have shown that 48-h ␤-adrenergic stimulation reduces the density of a variety of cardiac currents, including I K1 , I Ks , and I Ca L , and upregulates I Ca T , by ␤ 1 -receptor, cAMP-mediated mechanisms. These findings suggest that, in addition to altering ion channel function acutely, ␤-adrenergic agonists can have important longer term effects on ionic current density. These actions may be relevant to ionic remodeling in situations (like heart failure) with sustained increases in plasma catecholamine concentrations.
